News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Arndt Vogel: 1st line encorafenib + cetuximab + mFOLFOX6 vs SOC in BRAF V600E-mCRC
Arndt Vogel/X
Jun 1, 2025, 00:32

Arndt Vogel: 1st line encorafenib + cetuximab + mFOLFOX6 vs SOC in BRAF V600E-mCRC

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, posted on X:

“1st line encorafenib + cetuximab + mFOLFOX6 vs SOC in BRAF V600E-mCRC
BREAKWATER: PFS + updated OS
ASCO25
ORR 65 vs 37 vs 43 %
mPFS 12.8 vs 7.1 vs 6.9 mo
mOS 30.3 vs 15.1 vs 19.1 mo
AE ≥3 76% vs 58 vs 15.7%
Really effective, new SOC in 1st line.”

Arndt Vogel

Arndt Vogel ASCO25 BREAKWATER cancer OncoDaily Oncology
Special Coverage
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International
Blog
Jul 1, 2025, 09:34
Jasmine Kamboj: Congratulating the New Co-Leads of the Community of Practice Policy
Dialogues
Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer
Blog
Jul 1, 2025, 09:25
Alexandre Chan's Final Reflection on MASCC 2025
Dialogues
Jul 1, 2025, 09:21
Women Leaders in Oncology: Nina Mojas on GSK’s Oncology Growth and Innovation Strategy